COVID-19 research update 2
Zoom meeting
Programme
COVID-19 research update – Simon Collins
Slides and meeting report
COVID-19 research update 2 Zoom recording on YouTube
COVID-19 research update presentation slides
PHE report: Disparities in the risk and outcomes of COVID-19
PHE: Disparities in the risk and outcomes of COVID-19 – data pack
Financial support
The UK-CAB receives unrestricted funding from some pharmaceutical companies towards the direct costs of holding four meetings each year.
This funding supports the travel and accommodation costs for members to attend from outside London, plus the cost of catering. The content, programme and agenda for meetings is decided by the UK-CAB steering group in consultation with the wider membership. Funding is unconnected to meeting content.
Companies that develop and market medicines have a responsibility to actively engage with advocacy organisations. HIV positive people and their advocates should also be able to ask manufacturers directly about the safety and efficacy of their products. We should be involved in their proposals for future research.
For a list of companies that support the UK-CAB please see the “about us” page.